BCAB BioAtla, Inc.
-
BioAtla Reported Earnings
Thursday, August 13, 2026 · 12:00 AM ET
BioAtla (BCAB) reported earnings of $0.14 per share on revenue of $6.50 million for the . .
ioAtla is a global clinical-stage biotechnology company with operations in San Diego, California, and in Beijing, China through our contractual relationship with BioDuro-Sundia, a provider of preclinical development services.
Earnings Whisper Grade
—
Power Rating—
Reported Earnings
$0.14
Earnings Whisper®
—
Consensus Estimate
—
Earnings Surprise
Earnings Growth
Reported Revenue
$6.50M
Revenue Estimate
—
Revenue Surprise
Revenue Growth—